Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 10

1.

Best practices on immunomodulators and biologic agents for ulcerative colitis and Crohn's disease in Asia.

Ooi CJ, Hilmi I, Banerjee R, Chuah SW, Ng SC, Wei SC, Makharia GK, Pisespongsa P, Chen MH, Ran ZH, Ye BD, Park DI, Ling KL, Ong D, Ahuja V, Goh KL, Sollano J, Lim WC, Leung WK, Ali RAR, Wu DC, Ong E, Mustaffa N, Limsrivilai J, Hisamatsu T, Yang SK, Ouyang Q, Geary R, De Silva JH, Rerknimitr R, Simadibrata M, Abdullah M, Leong RW; Asia Pacific Association of Gastroenterology (APAGE) Working Group on Inflammatory Bowel Disease and Asian Organization for Crohn’s and Colitis.

Intest Res. 2019 Jul;17(3):285-310. doi: 10.5217/ir.2019.00026. Epub 2019 May 31. Review.

2.

Safety of drugs used for the treatment of Crohn's disease.

Pudipeddi A, Kariyawasam V, Haifer C, Baraty B, Paramsothy S, Leong RW.

Expert Opin Drug Saf. 2019 May;18(5):357-367. doi: 10.1080/14740338.2019.1612874. Epub 2019 May 6. Review.

PMID:
31026401
3.

Molecular Pathophysiology of Epithelial Barrier Dysfunction in Inflammatory Bowel Diseases.

Lee JY, Wasinger VC, Yau YY, Chuang E, Yajnik V, Leong RW.

Proteomes. 2018 Mar 31;6(2). pii: E17. doi: 10.3390/proteomes6020017. Review.

4.

Crohn's disease associated strictures.

Chan WPW, Mourad F, Leong RW.

J Gastroenterol Hepatol. 2018 May;33(5):998-1008. doi: 10.1111/jgh.14119. Epub 2018 Mar 12. Review.

PMID:
29427364
5.

Gastroenterologist perceptions of faecal microbiota transplantation.

Paramsothy S, Walsh AJ, Borody T, Samuel D, van den Bogaerde J, Leong RW, Connor S, Ng W, Mitchell HM, Kaakoush NO, Kamm MA.

World J Gastroenterol. 2015 Oct 14;21(38):10907-14. doi: 10.3748/wjg.v21.i38.10907.

6.

Persistence to oral 5-aminosalicylate therapy for inflammatory bowel disease in Australia.

Selinger CP, Kemp A, Leong RW.

Expert Rev Gastroenterol Hepatol. 2014 Mar;8(3):329-34. doi: 10.1586/17474124.2014.882768. Epub 2014 Feb 4.

PMID:
24490626
7.

Pregnancy related issues in inflammatory bowel disease: evidence base and patients' perspective.

Selinger CP, Leong RW, Lal S.

World J Gastroenterol. 2012 Jun 7;18(21):2600-8. doi: 10.3748/wjg.v18.i21.2600. Review.

8.

The Asia-Pacific consensus on ulcerative colitis.

Ooi CJ, Fock KM, Makharia GK, Goh KL, Ling KL, Hilmi I, Lim WC, Kelvin T, Gibson PR, Gearry RB, Ouyang Q, Sollano J, Manatsathit S, Rerknimitr R, Wei SC, Leung WK, de Silva HJ, Leong RW; Asia Pacific Association of Gastroenterology Working Group on Inflammatory Bowel Disease.

J Gastroenterol Hepatol. 2010 Mar;25(3):453-68. doi: 10.1111/j.1440-1746.2010.06241.x. Review.

PMID:
20370724
9.

Thiopurine hepatotoxicity in inflammatory bowel disease: the role for adding allopurinol.

Leong RW, Gearry RB, Sparrow MP.

Expert Opin Drug Saf. 2008 Sep;7(5):607-16. doi: 10.1517/14740338.7.5.607 . Review.

PMID:
18759713
10.

Helicobacter pylori eradication therapy: indications, efficacy and safety.

Kwok A, Lam T, Katelaris P, Leong RW.

Expert Opin Drug Saf. 2008 May;7(3):271-81. doi: 10.1517/14740338.7.3.271 . Review.

PMID:
18462185

Supplemental Content

Loading ...
Support Center